Arkolith/Insider Trading/ZIOP/Form 4

Boyle Kevin S. Sr.

Chief Executive Officer, DirectorZIOPHARM ONCOLOGY INC (ZIOP) · full profile →Form 4 · filed Aug 31, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 30, 2021Grant(A)875K—$0875K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 30, 2021Grant(A)2.6M—$02.6M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-054089) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML